Innolink Fund

Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.

Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.

Terminus Technologies, established in 2015 and headquartered in Beijing, specializes in developing Internet of Things (IoT) and Artificial Intelligence (AI) platforms for urban management. The company offers hardware for data collection, IoT platforms, and AI-driven applications, focusing on city management, building energy consumption, and property management. Their mission is to provide high-quality, interconnected solutions for sustainable urban development, with a particular emphasis on AI cities and robotics.

Rokae is a manufacturer specializing in the research, development, and production of lightweight industrial robots and robot control systems. The company is dedicated to enhancing industrial automation by offering high-performance robotic products and interactive control systems. Its solutions are utilized across various sectors, including computing, communications, consumer electronics, textiles, food, medicine, and automotive manufacturing. Rokae aims to add value for high-end manufacturing clients through its commitment to independent research and development, focusing on both robot hardware and integrated application solutions.

Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.

Ruipeng Pet Hospital, located in Shenzhen, specializes in a comprehensive range of pet care services. The hospital provides medical and beauty care for pets, including healthcare, foster care, bathing, SPA treatments, grooming, food, and entertainment. By offering both digital and clinical services, Ruipeng aims to ensure that pet owners can access high-quality care for their animals efficiently. The organization also includes online shopping options to further support pet owners in meeting their pets' needs.

Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices. With its advanced technology concept, Lansionbio provides equioment, reagents and services to world-wild clients according to their needs.

Daily Bacteria is a cutting-edge health food brand that provides a full range of "probiotics+" products for exquisite middle-class women aged 25-35. According to official information, the product was officially launched on July 1, 2021, and 3 SKUs have been launched. The main product is probiotic chewable tablets, with no added sucrose, and the sweetness comes from fruit powder. Recently announced the completion of a Pre-A round of financing of tens of millions of yuan, but the investor did not disclose it. It is understood that this round of financing will be mainly used for R&D investment, supply chain upgrades and channel expansion.

Sizone Technology is a specialized company focused on the development and manufacturing of chemical mechanical planarization (CMP) equipment for the semiconductor industry. The firm engages in research and development, as well as sales, of integrated semiconductor manufacturing equipment, catering to the needs of high-tech sector applications. Through its expertise in polishing equipment, Sizone Technology aims to enhance the production processes within the semiconductor manufacturing landscape.

Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.

Hzymes Biotechnology is a high-tech company focused on the research and development of essential raw materials for the in vitro diagnostic industry. By leveraging five innovative enzyme creation technology platforms, Hzymes specializes in the large-scale manufacturing of high-quality enzymes. The company provides a range of products, including raw materials for in vitro diagnosis, green bio-catalytic enzymes, and molecular biological enzymes, alongside associated technical services. Hzymes is dedicated to enhancing the efficacy of treatments and research in medical institutions and hospitals, while also prioritizing global raw material supply security to improve human health and well-being.

Edge Medical Robotics, Inc. is a Shenzhen, China-based company that specializes in the design and development of advanced surgical equipment. Founded on May 4, 2017, the company is dedicated to researching and promoting cutting-edge smart technologies aimed at enhancing surgical safety and treatment efficacy. By focusing on the pursuit of excellence and refinement in its products, Edge Medical Robotics seeks to elevate health standards and improve overall social health outcomes.

Lansus Technologies Inc. is a fabless semiconductor company founded in 2015 and headquartered in Shenzhen, China, with a research center located in Shanghai. The company specializes in developing advanced chip solutions, focusing on radio frequency power amplifiers, switches, and radio-frequency front-end modules. Lansus Technologies provides industrial clients with power amplification solutions through wireless RF devices and systems, catering to sectors such as mobile communications, IoT home furnishings, and industrial electronics. With a commitment to promoting technological progress, the company emphasizes advancements in the radio frequency field while prioritizing sustainable development. Its product offerings include solutions for 5G and 4G wireless communications.

EdBeta Fund is a venture capital firm based in Beijing, China, founded in 2015. The firm specializes in early-stage investments in the education sector, focusing on innovative startups within the education and edtech industries. By targeting early-stage companies, EdBeta Fund aims to support the development of new ideas and technologies that can enhance educational experiences and outcomes.

Soocas (Shenzhen) Technology Co., Ltd., founded in 2015, is an Internet technology company focused on personal digital health care products. The company emphasizes independent research and development to create advanced, intelligent, and high-quality products. Its primary offerings include the Soocas sonic electronic toothbrush and a mobile application that enhances user experience. As part of Xiaomi's ecosystem, Soocas benefits from a team with extensive experience in product design and development, drawn from notable companies such as Huawei, Oral-B, and Philips. The brand's flagship product, the X3 sonic electronic toothbrush, is backed by numerous patents in the field. With a commitment to the principles of passion, focus, and excellence, Soocas aims to continually improve its personal care products, which also include blow dryers and shaving razors.

Tianxi Kitchen Appliances manufactures kitchen appliances and cookers.

Iristar provides smart module, intelligent terminal, enterprise service innovation, smart customs clearance, smart security, smart finance, intelligence test, and smart factory services.

Peijia Medical Limited is a medical device company based in Suzhou, China, that specializes in the research, development, production, and sales of interventional procedural devices aimed at treating structural heart and neurovascular diseases. Founded in 2012, the company focuses on innovative products including various generations of transcatheter aortic valve replacement systems, as well as devices for transcatheter mitral and tricuspid valve replacements. In addition to its core offerings in heart valve therapies, Peijia Medical is advancing a range of ancillary products such as lithotripsy and balloon aortic valvuloplasty catheters, guidewires, and mitral repair devices. The company's neurointerventional product line includes stent retrievers, aspiration catheters, and detachable coils. With a commitment to high-quality medical technologies, Peijia Medical operates within a modern facility that supports its extensive R&D efforts in the growing interventional medical device market.

Yuanyi Investment is an alternative investment platform founded in mid-2016, focusing on expansion stage growth investments across various industries, including automotive, education, medical, corporate services, new energy, and environmental protection. The firm was initiated by Far East Horizon and established in collaboration with prominent financial holding companies and insurance firms, both domestic and international. Yuanyi Investment aims to foster innovation and development in these sectors by providing capital and strategic support to promising enterprises.

Fibonacci VC is a venture capital firm that invests in industrial Internet companies.

Shanghai MicroPort MedBot (Group) Co., Ltd. specializes in the design, development, and commercialization of surgical robots aimed at enhancing the capabilities of surgeons during complex procedures. Established in 2015, the company initially focused on endoscopic surgical robots and later expanded its efforts to include orthopedic surgical robots. MedBot's innovations are rooted in advanced research and the integration of robotics, intelligent control, and sensing technologies, positioning it as a leader in minimally invasive surgery. The company's operations primarily generate revenue from the People's Republic of China, with additional contributions from markets in the United States and Europe. Through its commitment to advancing robotic surgical solutions, MedBot aims to improve surgical outcomes and reshape the landscape of surgical practices.

Ally Capital is a private equity fund focuses on investments in the artificial intelligent and big data fields.

FutureCap is an early-stage venture capital firm based in Beijing, China, founded in 2014. The firm focuses on investing in internet companies across various sectors, including customer services, enterprise services, hardware, healthcare, and education. By targeting early-stage investments, FutureCap aims to support and nurture innovative businesses in the rapidly evolving Chinese market.

ZJU Joint Innovation Investment is a venture capital firm established in 2014 and located in Hangzhou, China. The firm focuses on innovative industrial investments, specifically targeting sectors such as new energy, integrated circuits, new materials, and artificial intelligence. Through its strategic investments, ZJU Joint Innovation Investment aims to foster technological advancements and support the growth of emerging industries in China.

CD Capital is a venture capital firm specializing in life sciences and medical technology, managing both RMB and USD funds totaling $600M. The firm, led by a team with diverse industry backgrounds, focuses primarily on investments in the China healthcare industry. With a track record of over 40 high-growth potential investments, CD Capital has established itself as a premier venture capital firm. Leveraging a wide network in China and globally, the firm aims to identify and capitalize on investment opportunities, shaping the future of healthcare in China. CD Capital's ultimate goal is to nurture top-tier companies and provide strong financial returns to its investors.